[Influencing the immune status of cancer patients through chemotherapy].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*; D011687:Purines / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000037:antagonists & inhibitors
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D011687:Purines; D011743:Pyrimidines
Beeinflussung des Immunstatus von Krebspatienten durch Chemotherapie